|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/38 | (2006.01) |
| A61K 31/727 | (2013.01) | ||
| A61K 31/727 | (2006.01) | ||
| A61K 38/57 | (2013.01) | ||
| A61K 35/16 | (2015.01) | ||
| C12Y 304/21027 | (2013.01) | ||
| A61K 38/385 | (2013.01) | ||
| A61K 38/57 | (2006.01) | ||
| A61P 1/00 | (2006.01) | ||
| C12Y 304/21038 | (2013.01) | ||
| A61P 7/02 | (2006.01) | ||
| C12Y 304/21008 | (2013.01) | ||
| A61P 9/06 | (2006.01) | ||
| A61K 35/16 | (2013.01) | ||
| A61P 9/12 | (2006.01) | ||
| A61P 1/00 | (2018.01) | ||
| A61P 11/08 | (2006.01) | ||
| A61P 11/08 | (2018.01) | ||
| A61P 7/02 | (2018.01) | ||
| A61P 9/06 | (2018.01) | ||
| A61P 9/12 | (2018.01) |
| (11) | Patento numeris | 3260124 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17181203.5 |
| Europos patento paraiškos padavimo data | 2012-05-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-12-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-07-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 11165869 | 2011-05-12 | EP | |
| 201161487205 P | 2011-05-17 | US |
| (72) |
Schulte, Stefan , DE
Kalina, Uwe , DE
Moses, Michael , DE
Feussner, Annette , DE
|
| (73) |
CSL Behring GmbH ,
Emil-von-Behring-Strasse 76, 35041 Marburg,
DE
|
| (54) | METHODS TO REDUCE ADVERSE EVENTS CAUSED BY PHARMACEUTICAL PREPARATIONS COMPRISING PLASMA DERIVED PROTEINS |
| METHODS TO REDUCE ADVERSE EVENTS CAUSED BY PHARMACEUTICAL PREPARATIONS COMPRISING PLASMA DERIVED PROTEINS |